Search Results - "GOLDFRANK, Deborah"

Sexual health needs and educational intervention preferences for women with cancer by Stabile, Cara, Goldfarb, Shari, Baser, Raymond E., Goldfrank, Deborah J., Abu-Rustum, Nadeem R., Barakat, Richard R., Dickler, Maura N., Carter, Jeanne

“…Purpose To assess sexual/vaginal health issues and educational intervention preferences in women with a history of breast or gynecologic cancer. Methods…”
Get full text

Vaginal and sexual health treatment strategies within a female sexual medicine program for cancer patients and survivors by Carter, Jeanne, Stabile, Cara, Seidel, Barbara, Baser, Raymond E., Goldfarb, Shari, Goldfrank, Deborah J.

“…Purpose We sought to evaluate patient adherence and response to simple vaginal and sexual health treatment strategies in female cancer patients receiving…”
Get full text

A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors by Carter, Jeanne, Baser, Raymond E., Goldfrank, Deborah J., Seidel, Barbara, Milli, Lisania, Stabile, Cara, Canty, Jocelyn, Saban, Sally, Goldfarb, Shari, Dickler, Maura N., Gardner, Ginger J., Jewell, Elizabeth L., Sonoda, Yukio, Kollmeier, Marisa A., Alektiar, Kaled M.

“…Purpose To assess the feasibility and efficacy of a non-hormonal hyaluronic acid (HLA) vaginal gel in improving vulvovaginal estrogen-deprivation symptoms in…”
Get full text

A single-arm clinical trial investigating the effectiveness of a non-hormonal, hyaluronic acid-based vaginal moisturizer in endometrial cancer survivors by Carter, Jeanne, Goldfarb, Shari, Baser, Raymond E., Goldfrank, Deborah J., Seidel, Barbara, Milli, Lisania, Saban, Sally, Stabile, Cara, Canty, Jocelyn, Gardner, Ginger J., Jewell, Elizabeth L., Sonoda, Yukio, Kollmeier, Marisa A., Alektiar, Kaled M.

“…To assess the efficacy of non-hormonal, hyaluronic acid (HLA)-based vaginal gel in improving vulvovaginal estrogen-deprivation symptoms in women with a history…”
Get full text

Risk-Reducing Bilateral Salpingo-Oophorectomy for Ovarian Cancer: A Review and Clinical Guide for Hereditary Predisposition Genes by Liu, Ying L, Breen, Kelsey, Catchings, Amanda, Ranganathan, Megha, Latham, Alicia, Goldfrank, Deborah J, Grisham, Rachel N, Long Roche, Kara, Frey, Melissa K, Chi, Dennis S, Abu-Rustum, Nadeem, Aghajanian, Carol, Offit, Kenneth, Stadler, Zsofia K

“…Pathogenic germline variants underlie up to 20% of ovarian cancer (OC) and are associated with varying degrees of risk for OC. For mutations in high-penetrance…”
Get more information

Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations by Shu, Catherine A, Pike, Malcolm C, Jotwani, Anjali R, Friebel, Tara M, Soslow, Robert A, Levine, Douglas A, Nathanson, Katherine L, Konner, Jason A, Arnold, Angela G, Bogomolniy, Faina, Dao, Fanny, Olvera, Narciso, Bancroft, Elizabeth K, Goldfrank, Deborah J, Stadler, Zsofia K, Robson, Mark E, Brown, Carol L, Leitao, Jr, Mario M, Abu-Rustum, Nadeem R, Aghajanian, Carol A, Blum, Joanne L, Neuhausen, Susan L, Garber, Judy E, Daly, Mary B, Isaacs, Claudine, Eeles, Rosalind A, Ganz, Patricia A, Barakat, Richard R, Offit, Kenneth, Domchek, Susan M, Rebbeck, Timothy R, Kauff, Noah D

“…The link between BRCA mutations and uterine cancer is unclear. Therefore, although risk-reducing salpingo-oophorectomy (RRSO) is standard treatment among women…”
Get more information

Reducing False-Positive Pregnancy Test Results in Patients With Cancer by McCash, Samuel I., Goldfrank, Deborah J., Pessin, Melissa S., Ramanathan, Lakshmi V.

“…To assess whether the use of a laboratory test specific for intact human chorionic gonadotropin (hCG) would reduce the number of false-positive pregnancy test…”
Get full text

Validation of Clinical Tools for Vaginal and Vulvar Symptom Assessment in Cancer Patients and Survivors by Eaton, Anne A., Baser, Raymond E., Seidel, Barbara, Stabile, Cara, Canty, Jocelyn P., Goldfrank, Deborah J., Carter, Jeanne

“…Health care professionals can play a pivotal role in promoting vulvovaginal health through assessment and appropriate intervention. To develop and validate…”
Get full text

Pilot study of rapid MR pancreas screening for patients with BRCA mutation by Corrias, Giuseppe, Raeside, Mitchell C., Agostini, Andrea, Huicochea-Castellanos, Sandra, Aramburu-Nunez, David, Paudyal, Ramesh, Shukla-Dave, Amita, Smelianskaia, Olga, Capanu, Marinela, Zheng, Junting, Fung, Maggie, Kelsen, David P., Mangino, Debra A., Robson, Mark E., Goldfrank, Deborah J., Carter, Jean, Allen, Peter J., Conti, Bettina, Monti, Serena, Do, Richard K. G., Mannelli, Lorenzo

“…Purpose To develop and optimize a rapid magnetic resonance imaging (MRI) screening protocol for pancreatic cancer to be performed in conjunction with breast…”
Get full text

Baseline characteristics and concerns of female cancer patients/survivors seeking treatment at a Female Sexual Medicine Program by Carter, Jeanne, Stabile, Cara, Seidel, Barbara, Baser, Raymond E., Gunn, Abigail R., Chi, Stephanie, Steed, Rebecca F., Goldfarb, Shari, Goldfrank, Deborah J.

“…Purpose The purpose of this study is to characterize patients seeking treatment at a Female Sexual Medicine and Women’s Health Program and examine their…”
Get full text

Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patients by Oseledchyk, Anton, Gemignani, Mary L, Zhou, Qin C, Iasonos, Alexia, Elahjji, Rahmi, Adamou, Zara, Feit, Noah, Goldfarb, Shari B, Long Roche, Kara, Sonoda, Yukio, Goldfrank, Deborah J, Chi, Dennis S, Saban, Sally S, Broach, Vance, Abu-Rustum, Nadeem R, Carter, Jeanne, Leitao, Mario, Zivanovic, Oliver

“…Ovarian suppression is recommended to complement endocrine therapy in premenopausal women with breast cancer and high-risk features. It can be achieved by…”
Get more information

Vulvar lichen sclerosus in the setting of cancer treatment – A case series and review of the literature by Geisler, Amaris, Lacouture, Mario E., Goldfrank, Deborah, Noor, Sarah

Get full text

Gynecologic Survivorship Tool: Development, Implementation, and Symptom Outcomes by Carter, Jeanne, Abu-Rustum, Nadeem R, Saban, Sally, Chen, Ling Y, Vickers, Andrew J, Tin, Amy L, Billanti, Gabriela, Connors, Nicole A, Broach, Vance, Brown, Carol L, Chi, Dennis S, Gardner, Ginger J, Goldfrank, Deborah J, Jewell, Elizabeth L, Leitao, Jr, Mario M, Long Roche, Kara C, Mueller, Jennifer J, Sonoda, Yukio, Zivanovic, Oliver

“…To describe the development and implementation of a new digital health clinical tool (Gynecologic Survivorship Tool [GST]) for symptom management of women…”
Get more information

Effect of Mammography on Breast Cancer Risk in Women with Mutations in BRCA1 or BRCA2 by GOLDFRANK, Deborah, CHUAI, Shannon, ROBSON, Mark, BERNSTEIN, Jonine L, Y CAJAL, Teresa Ramon, LEE, Johanna B, ALONSO, M. Carmen, DIEZ, Orland, BAIGET, Monserrat, KAUFF, Noah D, OFFIT, Kenneth

“…Women who carry mutations in either the BRCA1 or BRCA2 genes are at risk for early-onset breast cancer and are recommended to begin screening mammography at…”
Get full text

Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation-Negative Hereditary Breast Cancer Families by Kauff, Noah D., Mitra, Nandita, Robson, Mark E., Hurley, Karen E., Chuai, Shaokun, Goldfrank, Deborah, Wadsworth, Eve, Lee, Johanna, Cigler, Tessa, Borgen, Patrick I., Norton, Larry, Barakat, Richard R., Offit, Kenneth

“…Women from site-specific hereditary breast cancer families who carry a BRCA1 or BRCA2 mutation are at increased risk for ovarian cancer. It is less clear,…”
Get full text

Hereditary ovarian cancer in Ashkenazi Jews by Robles-Díaz, Luis, Goldfrank, Deborah J, Kauff, Noah D, Robson, Mark, Offit, Kenneth

“…Ovarian cancer is the fourth leading cause of cancer deaths among American women. While women in both the Ashkenazi and non-Ashkenazi populations have an…”
Get full text

Simple Strategies for Vaginal Health Promotion in Cancer Survivors by Carter, Jeanne, Goldfrank, Deborah, Schover, Leslie R.

“…With the population of cancer survivors nearing 12 million, an ever‐increasing number of women will face vaginal health issues related to their disease and/or…”
Get full text

Breast cancer patients in a female sexual medicine and women’s health program: A cross-sectional retrospective study by Carter, Jeanne, Saban, Sally, Arkema, Ashley, Goldfrank, Deborah J., Goldfarb, Shari Beth

“…Abstract only 8 Background: Cancer treatment impacts sexual health and QOL with symptoms of vulvovaginal dryness, dyspareunia, and sexual dysfunction. There…”
Get full text

Objective and subjective vulvovaginal symptoms in breast cancer patients by Goldfarb, Shari Beth, Saban, Sally, Arkema, Ashley, Patil, Sujata, Flynn, Jessica, Goldfrank, Deborah J., Norton, Larry, Carter, Jeanne

“…Abstract only e24056 Background: Breast cancer and its treatment adversely impact sexual function and QoL. As more women become survivors, information is…”
Get full text

Patient‐Reported Goals of Care in the Preoperative Clinic: Barriers to and Facilitators of Patient Values Elicitation and Documentation by Rosen, Roni Y., Bartsch, Christan, Thompson, Errika, Letica‐Kreigel, Allison, Kaur, Yashjot, Ng, Susan, Vaynrub, Maksim, Rosa, William E., Broach, Vance, Epstein, Andrew S., Nelson, Judith E., Nash, Garrett M., Goldfrank, Deborah

“…Infrequent preoperative goals of care (GOC) documentation leads to challenges in medical decision-making when patients experience postoperative complications…”
Get full text